Christopher Gannon, MD
Surgical Oncology · Hollywood, FLNPI 1962500207
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (29.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 49.5% of the total. Reporting peaked in 2024 at $5,720 and has fallen 64.6% since, to $2,025 in 2025.
Across 46 payments — averaging $217.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$5K
- Intuitive Surgical$2K
- Histosonics, Inc.$2K
- Biom'up SA$688
- Medical Device Business Services, Inc.$217
- Boston Scientific$209
- plus $407 from 4 others
What the payments were for
- Consulting fees$2,99930%
- Travel & lodging$2,95329%
- Food & beverage$2,92729%
- Education$1,13711%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 21 | $4,956 |
| Intuitive Surgical | 8 | $1,841 |
| Histosonics, Inc. | 2 | $1,698 |
| Biom'up SA | 5 | $688 |
| Medical Device Business Services, Inc. | 2 | $217 |
| Boston Scientific | 4 | $209 |
| AbbVie | 1 | $125 |
| Aroa Biosurgery Incorporated | 1 | $124 |
| Davol Inc. | 1 | $100 |
| Iovance Biotherapeutics, Inc. | 1 | $58 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,000
- Da Vinci Surgical System$707
- HEMOBLAST$587
- VISTASEAL$269
- STRATAFIX$256
- MONOCRYL$137
- DERMABOND PRINEO$137
- STRATTICE$125
- ENSEAL Product Family$119
- HABIB ENDOHPB$113
- Echelon Powered Circular$107
- Phasix Mesh$100
How this compares
$10,017 in reported general payments places this provider in the 75th percentile of 133 surgical oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 11 | $105 |
| Tramadol Hcl | 31 | $55 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Hollywood
- Neha GoelMiami$200K
- Jonathan ZagerTampa$191K
- Horacio AsbunMiami$161K
- Adrian Legaspi SauterHialeah$116K
- Kenneth MeredithSarasota$113K
- Pamela HodulTampa$94K
- Mehran HabibiMiami$73K
- Paul BloomstonFort Myers$68K
- Kristin RojasMiami$57K
- Douglas ReintgenTarpon Springs$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.